Now Is The Time To Build A Position In Molecular Templates Inc (NASDAQ:MTEM)

In last trading session, Molecular Templates Inc (NASDAQ:MTEM) saw 11.42 million shares changing hands with its beta currently measuring 1.15. Company’s recent per share price level of $0.33 trading at -$0.01 or -3.79% at ring of the bell on the day assigns it a market valuation of $2.14M. That closing price of MTEM’s stock is at a discount of -1927.27% from its 52-week high price of $6.69 and is indicating a premium of 12.12% from its 52-week low price of $0.29. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.11 million shares which gives us an average trading volume of 196.63K if we extend that period to 3-months.

Molecular Templates Inc (NASDAQ:MTEM) trade information

Upright in the red during last session for losing -3.79%, in the last five days MTEM remained trading in the red while hitting it’s week-highest on Friday, 10/11/24 when the stock touched $0.33 price level, adding 77.7% to its value on the day. Molecular Templates Inc’s shares saw a change of -91.28% in year-to-date performance and have moved -77.73% in past 5-day. Molecular Templates Inc (NASDAQ:MTEM) showed a performance of -75.18% in past 30-days. Number of shares sold short was 0.14 million shares which calculate 3.02 days to cover the short interests.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Molecular Templates Inc (MTEM) estimates and forecasts

This year revenue growth is estimated to fall -78.50% from the last financial year’s standing.

1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 330k for the same. And 1 analysts are in estimates of company making revenue of 340k in the next quarter. Company posted 6.8M and 7.02M of sales in current and next quarters respectively a year earlier.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 34.83% during past 5 years. In 2024, company’s earnings growth rate is likely to be around -62.78% while estimates for its earnings growth in next 5 years are of 3.20%.

Molecular Templates Inc (NASDAQ:MTEM)’s Major holders

Insiders are in possession of 3.96% of company’s total shares while institution are holding 56.12 percent of that, with stock having share float percentage of 58.43%. Investors also watch the number of corporate investors in a company very closely, which is 56.12% institutions for Molecular Templates Inc that are currently holding shares of the company.

On the other hand, Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Jun 30, 2024 , the former fund manager was holding 49.89 shares of worth $16213.0 or 0.76% of the total outstanding shares. The later fund manager was in possession of 27.86 shares on Aug 31, 2024 , making its stake of worth around $9054.0 in the company or a holder of 0.42% of company’s stock.